Janus Henderson Transformational Growth ETF
JXX - ETF AI Analysis
Top Page
Janus Henderson Transformational Growth ETF (JXX)
JXX, the Janus Henderson Transformational Growth ETF, has a solid but not top-tier rating, reflecting a mix of strong growth leaders and a few more challenged holdings. High-quality positions like TSM and Broadcom support the fund’s standing through strong financial performance and clear growth opportunities in advanced chips and AI, while Boeing’s financial difficulties and delays act as a drag. The main risk is the fund’s meaningful exposure to richly valued, growth-focused technology and semiconductor names, which could be more volatile if high expectations are not met.
JXX vs. SPDR S&P 500 ETF (SPY)
- AUM
- 21.25M
- Region
- North America
- Expense Ratio
- 0.57%
- Beta
- 1.41
- Issuer
- Janus Henderson
- Inception Date
- Feb 04, 2025
- Dividend Yield
- 0.04%
- Asset Class
- Equity
- Index Tracked
- No Underlying Index
JXX Summary
Janus Henderson Transformational Growth ETF (JXX) is an actively managed fund that focuses on innovative large companies, mainly in technology and healthcare, rather than tracking a fixed index. It aims to find businesses driving advances in areas like artificial intelligence and medical treatments. The fund holds well-known names such as Amazon and TSMC, giving investors exposure to companies with strong growth potential in cutting-edge fields. Someone might invest in JXX to seek long-term growth and diversify into leading innovators. A key risk is that these growth-focused stocks can be more volatile and may go up and down sharply with market conditions.
How much will it cost me?
JXX has an annual expense ratio of 0.57%, which means you’ll pay about $5.70 per year for every $1,000 invested. This cost is higher than the average ETF because it’s actively managed, with professionals selecting a focused portfolio of innovative growth companies rather than simply tracking a broad market index.
What would affect this ETF?
JXX could benefit if demand for AI, cloud computing, and healthcare innovation continues to grow, supporting major holdings like TSMC, Amazon, Oracle, and UnitedHealth, and if the U.S. economy remains healthy enough to sustain spending in technology and consumer-related industries. On the downside, higher interest rates, tighter regulations on big tech or healthcare, supply chain issues affecting chipmakers and industrial names, or a slowdown in U.S. growth could hurt these companies and make this concentrated, growth-focused ETF more volatile.
JXX Top 10 Holdings
JXX is leaning hard into AI and innovation, with chip makers and cloud players setting the tone. AMD and Lumentum have been rising, giving the fund a strong tailwind from the semiconductor side, while TSM has been steadier, acting like a reliable engine rather than a rocket. On the flip side, Broadcom and Oracle have been lagging, and Amazon’s performance has been mixed, which together drag on returns. Danaher and UnitedHealth add a steadier healthcare ballast. Overall, it’s a U.S.-centric, tech-and-healthcare-heavy bet on transformational growth.
| Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| TSMC | 11.66% | $2.44M | $1.85T | 31.12% | 81Outperform | |
| Amazon | 9.20% | $1.92M | $2.88T | 9.83% | 71Outperform | |
| Oracle | 7.59% | $1.59M | $379.03B | -46.56% | 66Neutral | |
| Broadcom | 7.06% | $1.48M | $1.66T | -2.65% | 76Outperform | |
| Howmet Aerospace | 5.42% | $1.13M | $87.81B | 4.70% | 67Neutral | |
| Danaher | 5.08% | $1.06M | $163.94B | 3.93% | 75Outperform | |
| Advanced Micro Devices | 4.68% | $978.93K | $875.91B | 104.32% | 73Outperform | |
| Eli Lilly & Co | 4.77% | $995.76K | $1.36T | 39.64% | 72Outperform | |
| UnitedHealth | 4.74% | $990.94K | $365.09B | 28.01% | 72Outperform | |
| Boeing | 4.04% | $843.78K | $135.91B | -15.06% | 54Neutral |
JXX Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For JXX, the sentiment is Negative. The current price of 26.80 is below the 20-day moving average (MA) of 28.58, below the 50-day MA of 30.23, and below the 200-day MA of 29.53, indicating a bearish trend. The MACD of -0.75 indicates Negative momentum. The RSI at 42.78 is Neutral, neither overbought nor oversold. The STOCH value of 81.55 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for JXX.
JXX Peer Comparison
Comparison Results
| Name | Price | Price Target | AUM | Expense Ratio | Overall Rating |
|---|---|---|---|---|---|
| $26.80 | $30.00(11.94% Upside) | $21.25M | 0.57% | 64Neutral | |
| $23.42 | $30.51(30.27% Upside) | $49.77M | 0.88% | 75Outperform | |
| $23.34 | $31.22(33.72% Upside) | $43.39M | 0.35% | 68Neutral | |
| $20.95 | $33.12(58.08% Upside) | $41.60M | 0.65% | 70Outperform | |
| $25.60 | $36.07(40.89% Upside) | $29.40M | 0.77% | 71Outperform | |
| $22.72 | $33.05(45.48% Upside) | $945.77K | 0.75% | 70Outperform |
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| JXX | Janus Henderson Transformational Growth ETF | 26.80 | -0.28 | -1.05% | |
| TMGN | TappAlpha Cboe Magnificent 10 Growth & Daily Income ETF | 23.42 | 0.30 | 1.29% | |
| CCSO | Carbon Collective Climate Solutions U.S. Equity ETF | 23.34 | -0.53 | -2.22% | |
| BUIL | Rebuild America ETF | 20.95 | -3.91 | -15.72% | |
| GK | AdvisorShares Gerber Kawasaki ETF | 25.60 | 0.68 | 2.72% | |
| GANZ | Tuttle Capital Thematic ETF | 22.72 | -2.07 | -8.37% |
This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
